1. Home
  2. MYSZ vs ENSC Comparison

MYSZ vs ENSC Comparison

Compare MYSZ & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYSZ
  • ENSC
  • Stock Information
  • Founded
  • MYSZ 1999
  • ENSC 2003
  • Country
  • MYSZ Israel
  • ENSC United States
  • Employees
  • MYSZ N/A
  • ENSC N/A
  • Industry
  • MYSZ Computer Software: Prepackaged Software
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYSZ Technology
  • ENSC Health Care
  • Exchange
  • MYSZ Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • MYSZ 8.2M
  • ENSC 7.9M
  • IPO Year
  • MYSZ N/A
  • ENSC N/A
  • Fundamental
  • Price
  • MYSZ $1.79
  • ENSC $5.80
  • Analyst Decision
  • MYSZ Strong Buy
  • ENSC
  • Analyst Count
  • MYSZ 1
  • ENSC 0
  • Target Price
  • MYSZ $3.00
  • ENSC N/A
  • AVG Volume (30 Days)
  • MYSZ 140.8K
  • ENSC 53.4K
  • Earning Date
  • MYSZ 03-31-2025
  • ENSC 03-14-2025
  • Dividend Yield
  • MYSZ N/A
  • ENSC N/A
  • EPS Growth
  • MYSZ N/A
  • ENSC N/A
  • EPS
  • MYSZ N/A
  • ENSC N/A
  • Revenue
  • MYSZ $9,632,000.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • MYSZ $35.62
  • ENSC $89.78
  • Revenue Next Year
  • MYSZ $12.88
  • ENSC N/A
  • P/E Ratio
  • MYSZ N/A
  • ENSC N/A
  • Revenue Growth
  • MYSZ 43.89
  • ENSC 40.41
  • 52 Week Low
  • MYSZ $1.05
  • ENSC $2.12
  • 52 Week High
  • MYSZ $9.40
  • ENSC $14.85
  • Technical
  • Relative Strength Index (RSI)
  • MYSZ 41.61
  • ENSC 38.42
  • Support Level
  • MYSZ $1.67
  • ENSC $5.34
  • Resistance Level
  • MYSZ $2.30
  • ENSC $6.46
  • Average True Range (ATR)
  • MYSZ 0.17
  • ENSC 0.45
  • MACD
  • MYSZ -0.01
  • ENSC -0.07
  • Stochastic Oscillator
  • MYSZ 19.05
  • ENSC 20.08

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: